# Voyager Therapeutics, Inc.: Form 8-K, filed Aug 4, 2022

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2022-08-04
- Accepted by EDGAR: Aug 4, 2022, 16:27 ET
- Period: 2022-08-04
- Accession: 0001558370-22-012231
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000155837022012231/vygr-20220804x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000155837022012231/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000155837022012231/vygr-20220804x8k.htm

Filed Aug 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001558370-22-012231. Last ingested by Listed: Nov 5, 2026, 16:29 ET. No prices; not investment advice.
